Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin

被引:95
作者
Di Colo, G [1 ]
Zambito, Y [1 ]
Burgalassi, S [1 ]
Nardini, I [1 ]
Saettone, MF [1 ]
机构
[1] Univ Pisa, Dept Bioorgan Chem & Biopharmaceut, I-56126 Pisa, Italy
关键词
ofloxacin; chitosan; N-carboxymethylchitosan; ocular drug delivery; pharmacokinetics; absorption enhancer;
D O I
10.1016/j.ijpharm.2003.12.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of chitosan hydrochloride (Ch-HCl) and of N-carboxymethylchitosan (CMCh), formulated in ophthalmic solutions, on the ocular pharmacokinetics of ofloxacin were studied in rabbits. The carboxymethylation of a chitosan of high molecular mass (1460 kDa) and deacetylation degree (89.9%) introduced 0.84 N-carboxymethyl groups per repeating unit. Aqueous solutions containing 1% (w/v) of either polymer showed a pseudoplastic rheologic behaviour, and, when instilled in rabbit eyes, produced no irritation. The kinetics of drug disappearance from tear fluid and the profiles of drug concentration in the aqueous humour versus time were determined and interpreted in the light of a pharmacokinetic model and of drug-polymer binding. Ch-HCl significantly enhanced intraocular drug penetration with respect to an isoviscous drug solution containing poly(vinyl alcohol) and to commercial ofloxacin eyedrops. This effect, which resulted in about 190% increase of the peak concentration in the aqueous, was ascribed to an increased corneal permeability. The polyanionic CMCh failed to enhance intraocular drug penetration. It nevertheless increased precorneal drug retention in virtue of its viscosity and of ofloxacin binding. Consequently, the residence time at concentrations higher than the MIC90 and the bioavailability of the antibiotic in the aqueous were increased by about 150 and 240%, respectively, with respect to the reference vehicle. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 18 条
[1]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[2]   Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor using different topical application modes [J].
Beck, R ;
van Keyserlingk, J ;
Fischer, U ;
Guthoff, R ;
Drewelow, B .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1999, 237 (02) :89-92
[3]   EVALUATION OF A DYNAMIC PERMEATION TECHNIQUE FOR STUDYING DRUG-MACROMOLECULE INTERACTIONS [J].
BOTTARI, F ;
DICOLO, G ;
NANNIPIERI, E ;
SAETTONE, MF ;
SERAFINI, MF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (06) :946-949
[4]  
Çekiç O, 1999, OPHTHALMIC SURG LAS, V30, P465
[5]   A study of release mechanisms of different ophthalmic drugs from erodible ocular inserts based on poly(ethylene oxide) [J].
Di Colo, G ;
Zambito, Y .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (02) :193-199
[6]   Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide) [J].
Di Colo, G ;
Zambito, Y ;
Burgalassi, S ;
Serafini, A ;
Saettone, MF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 248 (1-2) :115-122
[7]   Gel-forming erodible inserts for ocular controlled delivery of ofloxacin [J].
Di Colo, G ;
Burgalassi, S ;
Chetoni, P ;
Fiaschi, MP ;
Zambito, Y ;
Saettone, MF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 215 (1-2) :101-111
[8]   Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention [J].
Felt, O ;
Furrer, P ;
Mayer, JM ;
Plazonnet, B ;
Buri, P ;
Gurny, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 180 (02) :185-193
[9]  
Felt O, 2001, AAPS PHARMSCI, V3
[10]   CHITOSAN AS A NOVEL NASAL DELIVERY SYSTEM FOR PEPTIDE DRUGS [J].
ILLUM, L ;
FARRAJ, NF ;
DAVIS, SS .
PHARMACEUTICAL RESEARCH, 1994, 11 (08) :1186-1189